Clean Science & Technology Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Clean Science & Technology Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹900
Per ShareLot Size
16 Shares
Minimum Investment
₹14,400
Issue Size
₹1,546.622 Cr
Face Value
₹1
Per ShareIPO Type
Book Building
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Clean Science & Technology Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
29.78%
Issue Type
Book Building
ISIN
INE227W01023
About the Company
Clean Science and Technologies Ltd manufactures functionally critical specialty chemicals such as Performance Chemicals (i.e. MEHQ, BHA and AP), Pharmaceutical Intermediates (i.e. Guaiacol and DCC), and FMCG Chemicals (i.e. 4-MAP and Anisole). Its products are used as polymerization inhibitors, intermediates for agrochemicals and pharmaceuticals, anti-oxidants, UV blockers, and antiretroviral reagents, which are functionally critical in a wide range of industries, including in the manufacture of paints and inks, agro-chemicals, pharmaceuticals, flavours and fragrance, food and animal nutrition (feed), and personal care (cosmetics) products. Our Company was established on reen' or eco-friendly manufacturing processes led by differentiated catalytic technologies.
Industry Overview
Specialty chemicals are low-volume and high-value products which are sold on the basis of their quality or utility, rather than composition. Thus, they may be used primarily as additives or to provide a specific attribute to the end product. Specialty chemicals are more likely to be prepared and processed in batches. The focus is on value addition to the end-product and the properties or technical specifications of the chemical. Green chemistry is an emerging focus among manufacturing industries that minimizes pollution at a molecular level.
Company History
Clean Science and Technologies Ltd was incorporated as `Sri Distikemi Private Limited' on November 7, 2003 in Pune, Maharashtra as a private limited company under the Companies Act, 1956, as amended. Thereafter, the name of the Company was changed to `Clean Science and Technology Private Limited' pursuant to a resolution passed by its shareholders in an extraordinary general meeting held on July 31, 2006, and a fresh certificate of incorporation, dated August 25, 2006 was issued by the Registrar of Companies, Pune ("RoC"). Subsequently, the Company was converted into a public limited company pursuant to a resolution passed by its Shareholders at an extraordinary general meeting held on February 25, 2021 and a fresh certificate of incorporation dated March 4, 2021 was issued by the RoC consequent upon conversion, recording the change in the name of the Company to Clean Science and Technology Limited.
Products & Services
- Speciality Chemicals, including polymerization inhibitor products such as MEHQ
Growth Strategy
- Leverage its leadership position in the specialty chemicals industry to capitalize on industry opportunities
- Leverage its R&D capabilities and understanding of catalysis to continue process re-engineering, further enhancing its product portfolio
- Expand manufacturing capacities of existing products and set up additional capacities for new products
- Continue to strengthen its presence in India and expand its sales and distribution network in international markets
Customer Base
Wholesalers and Retailers
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial Public Offer of 17,184,682 equity shares of face value of Rs. 1 each ("equity shares") of Clean Science and Technology Limited ("company") for cash at a price of Rs. 900 per equity share through an offer for sale of 17,184,682 equity shares ("offer for sale" or "offer") aggregating to Rs.1546.62 Crores, consisting of 2,711,288 equity shares by Ashok Ramnarayan Boob aggregating to Rs.244.02 Crores, 2,145,100 equity shares by Krishnakumar Ramnarayan Boob* aggregating to Rs.193.06 Crores, 450,055 equity shares by Siddhartha Ashok Sikchi aggregating to Rs.40.51 Crores, 844,255 equity shares by Parth Ashok Maheshwari aggregating to Rs.75.98 Crores (collectively, the "promoter selling shareholders"), 2,711,288 equity shares by Asha Ashok Boob aggregatingto Rs.244.02 Crores, 1,511,677 equity shares by Ashokkumar Ramkishan Sikchi Huf aggregating to Rs.136.05 Crores, 461,677 equity shares by Krishnakumar Ramnarayan Boob Huf aggregating to Rs.41.55 Crores, 836,222 equity shares by Ashok Ramnarayan Boob Huf aggregating to Rs.75.26 Crores, 844,255 equity Shares by Nidhi Mohunta* aggregating to Rs.75.98 Crores, 934,188 equity shares by Nilima Krishnakumar Boob* aggregating to Rs.84.08 Crores, 489,200 equity shares by Shradha Krishnakumar Boob* aggregating to Rs.44.03 Crores, 489,200 equity shares by Prasad Krishnakumar Boob* aggregating to Rs.44.03 Crores, 489,200 equity shares by Pooja Vivek Navandar* aggregating to Rs.44.03 Crores, 1,268,200 equity shares by Asha Ashok Sikchi aggregating to Rs.114.14 Crores, 345,044 equity shares by Kunal Ashok Sikchi aggregating to Rs.31.05 Crores, 313,811 equity shares by Ashok Sikchi aggregating to Rs.28.24 Crores, 304,000 equity Shares by Nandita Sikchi aggregating to Rs.27.36 Crores and 36,022 equity shares by Ganapati Dadasaheb Yadav aggregating to Rs.3.24 Crores (collectively, the ôother selling shareholdersö, together with promoter selling shareholders, the "selling shareholders"). * First Holders of equity shares. The face value of equity shares is Rs. 1 each. Offer Price : Rs. 900 per equity share of face value of Rs. 1 each. Anchor investor offer price : Rs. 900 per equity share. The Offer price is 900 times the face value.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Its track record of strategic process innovation through consistent R&D initiatives;
- Being among the largest producers globally of functionally critical specialty chemicals used across various industries and geographies resulting in a de-risked business model;
- Experienced Promoters and senior management with extensive domain knowledge;
- Strong and long-standing relationships with key customers;
- Automated manufacturing facilities with proven design and commercialization capabilities and strong focus on EHS;
- company's operations are dependent on its R&D capabilities and an inability to continue to design catalytic processes may adversely affect its business.
- None of our catalytic processes are patented and its intellectual property may not be adequately protected, which may have a material adverse impact on its business and results of operations.
- There have been certain instances of non-compliances and errors with respect to certain corporate actions and regulatory filings undertaken by its Company in the past. its Company has re-filed the relevant forms for the
- Company depend on the success of its relationships with our customers. A significant portion of its revenue is generated from certain key customers, and the loss of one or more such customers, the deterioration of their financial condition or prospects, or a reduction in their demand for its products could adversely affect its business, results of operations, financial condition and cash flows.
- Company have certain capital commitments that have not been provided for in its financial statements, which if they materialise, may adversely affect its financial condition.